UNIDOC HEALTH CORP Stock Price, News & Analysis

UniDoc Health Corp (OTC:UDOCF) amended its previously announced non-brokered private placement LIFE offering to include a minimum raise of $800,000 and retain a maximum of $1,500,000.

The Offering now covers a minimum of 5,333,333 Units and up to 10,000,000 Units at $0.15 per Unit. Each Unit includes one common share and one transferable warrant exercisable at $0.25 for 36 months. Proceeds are designated for inventory, marketing and investor relations, working capital, and general corporate purposes.

The Offering uses the listed issuer financing exemption under NI 45-106 (ex-Quebec), the securities for Canadian resident subscribers will not be subject to resale restrictions, and closing is expected on or about October 22, 2025 (or within 45 days of October 17, 2025), subject to customary approvals including the CSE.

UniDoc Health Corp. (OTCQB:UDOCF) has provided a comprehensive corporate update addressing several key developments. The company has completed filing its delayed annual financial statements for the year ended March 31, 2025, which had resulted in a Cease Trade Order (CTO) from the British Columbia Securities Commission. The delay was attributed to extended audit timelines and a required independent valuation of the AGNES Connect Software acquisition from AMD Global Telemedicine.

The company reports successful integration of AGNES software into its operations, with positive client response and contract renewals. UniDoc has also begun shipping its H3 Health Cube units and expects to announce customer installations soon. The company operates in the global telemedicine market, which is projected to grow from $146.9 billion in 2025 to $251.5 billion by 2030, representing an 11.3% CAGR.

UniDoc Health Corp. (OTCQB:UDOCF) announces its participation in the Ukraine Recovery Conference (URC2025), scheduled for July 10-11, 2025, in Rome, Italy. The conference, jointly hosted by Italy and Ukraine, aims to mobilize global support for Ukraine's reconstruction, modernization, and reform efforts.

The company will showcase its recent deployment of AI-powered H3 Health Cubes in Ukraine, including an installation at Yasinia Regional Hospital. The conference will bring together political leaders, international financial institutions, private sector representatives, and civil society members to address Ukraine's recovery and investment needs.

UniDoc Health has provided an update on its marketing engagement with Rumble Strip Media. The company spent approximately $3.84 million on investor relations marketing services since April 2024, successfully converting over 90% of outstanding warrants into $8.8 million in gross proceeds.

The company has begun commercial sales with purchase orders for 16 H3 Health Cube booths from four customers. Three booths have been delivered, with revenue expected from two units in Q4. UniDoc has raised approximately $13.4 million since 2021 through private placements ($3.7M) and convertible securities ($9.7M).

While not yet cashflow positive, UniDoc allocates funds primarily to general administration ($1.4M) and investor relations ($3.4M). The company expects investor relations marketing expenses to decrease significantly as operational expenditures increase in coming quarters, reflecting its transition from development to sales phase.

UniDoc Health Corp (CSE:UDOC) has announced a non-brokered private placement LIFE offering to raise up to $500,000 through the issuance of up to 2,000,000 units at $0.25 per unit. Each unit comprises one common share and one-half of a transferrable warrant, with each full warrant allowing the purchase of an additional common share at $0.35 for 24 months after closing.

The proceeds will support inventory, marketing and investor relations services, working capital, and general corporate purposes. The offering, expected to close around April 11, 2025, will be conducted under the listed issuer financing exemption in British Columbia, with securities issued to Canadian residents having no resale restrictions.

UniDoc Health Corp. (CSE:UDOC, FRA:L7T, OTCQB:UDOCF) announced plans to settle $93,240 in debt by issuing approximately 266,400 common shares at $0.35 per share. This Debt Settlement aims to conserve cash and improve financials by reducing liabilities. The settlement, involving a company controlled by a UniDoc director, is a 'related party transaction' under MI 61-101 but is exempt from formal valuation and minority shareholder approval requirements. The shares will have a four-month hold period.

Additionally, UniDoc has extended its engagement with Rumble Strip Media Inc. for social media, marketing, and consulting services for three more months starting April 4, 2025, at a cost of $500,000. This renewal aligns with UniDoc's financial resources and operational levels, supported by $3.7 million from private placements and $9.7 million from convertible securities since incorporation. The company believes Rumble's services are important for maintaining stock liquidity and investor awareness.

UniDoc Health Corp (OTCQB:UDOCF) has completed the acquisition of AGNES Connect software from AMD Telemedicine, as announced on March 28, 2025. The transaction, valued at US$175,000 plus a revenue share agreement, includes the acquisition of AMD Telemedicine's brand name, goodwill, software platform, intellectual property, and existing customer subscriptions.

The AGNES Connect software serves as the foundation for UniDoc's NEIL Connect software platform. CEO Antonio Baldassarre highlighted that AGNES Connect has an established national and international customer network and represents an opportunity for generating sustainable revenue through its existing commercial operations.

UniDoc Health Corp (OTCQB:UDOCF) has entered into a definitive purchase agreement to acquire AGNES Connect software from AMD Telemedicine for US$175,000 plus revenue share. The acquisition, expected to close shortly, includes the AMD Telemedicine name, related goodwill, software, intellectual property, trademarks, and customer subscriptions.

AGNES Connect is a secure cloud-based clinical examination platform that enables healthcare providers to exchange medical data, documents, and images in real-time with video conferencing capabilities. The software integrates with healthcare facilities' electronic health record (EHR) systems and will enhance UniDoc's NEIL Connect platform.

The NEIL Connect platform, integrated with Carefluence and DocBox software, leverages AI for intake/triage through MediOrbis and patient monitoring via DocBox. The platform maintains HIPAA compliance and ensures secure management of patient information.

UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF) announced it has filed an amended and restated Management's Discussion and Analysis (MD&A) for the six-month period ended September 30, 2024, following a continuous disclosure review by the British Columbia Securities Commission.

The company has revised its interim MD&A to include clarifying disclosure on four key areas: the nature of UniDoc's business, recent developments, contractual agreements, and explanations relating to advertising costs incurred by the company.

Shareholders can access the amended and restated MD&A under UniDoc's issuer profile on SEDAR+ at www.sedarplus.ca. The announcement was made on behalf of the Board of Directors by Antonio Baldassarre, who serves as CEO, President & Director of UniDoc Health Corp.